Asia Pacific Urinalysis Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Consumables and Instruments), Test Type (Pregnancy and Fertility Tests, Biochemical Urinalysis, and Sediment Urinalysis), Application (Disease Screening, and Pregnancy and Fertility), and End User (Hospitals and Clinics, Diagnostic Laboratories, Home Care Settings, Research Laboratories, and Institutes)

TIPRE00026264 | Pages: 156 | Medical Device | Dec 2021 | Type: Regional | Status: Published

Market Introduction

APAC consists of five major countries namely China, Japan, India, Australia, and South Korea. The market is also evaluated for the rest of countries in APAC. The market is driven by the factors such as increasing incidences of chronic diseases such as diabetes, kidney disorder and liver diseases, growing strategic developments in urinalysis market, and growing development for healthcare facilities that demand advanced urinalysis analyzers for accurate and precise diagnosis. Moreover, growing geriatric population in the region, and increasing number of diagnostic laboratories in this region will support the market growth during the forecast period.

The COVID-19 pandemic affected most programs in APAC, but to varying degrees. Medical device manufacturers and suppliers are shifting their focus on supplying essentials and medical devices related to the management of COVID-19. The shift in focus toward pandemic has disrupted the spectrum of kidney and renal care, including delayed diagnoses and treatment, and disrupted clinical trials. In response, healthcare systems are rapidly reorganizing cancer services to ensure that patients receive essential care while minimizing exposure to SARS-CoV-2 infection. Diagnostic testing service providers are coordinating with healthcare authorities to manage testing services residues, prioritize testing services, and use modern technology to overcome potential barriers. The increased adoption of at-home settings for urinalysis for the diagnosis of diseases such as UTIs, and other renal and kidney diseases tests also helped fill the gaps in screening. The transport restrictions imposed by various countries have had a major influence on international trade and commerce. India, too, has suffered owing to unexpected economic disruptions caused by interim restrictions on public activities and regional lockdowns. Asia’s value chains have closely integrated the economies of China, Japan, South Korea, Hong Kong, and other Asian countries. Such dense and extremely coordinated value chains enable massive economies of scale in manufacturing.     

Market Overview and Dynamics

The urinalysis market in APAC is expected to grow from US$ 917.20 million in 2021 to US$ 1,411.47 million by 2028; it is estimated to grow at a CAGR of 6.4% from 2021 to 2028. The rest of the APAC region includes Thailand, New Zealand, Singapore, Myanmar, Vietnam, and Hong Kong. The countries are developing fastest in terms of healthcare infrastructure that are involved in the rapid technological developments in diagnostic procedures and increasing trend of medical tourism in these countries due to cost effective medical procedures will support the development of urinalysis market. For instance, Sysmex Thailand a leading provider of automated urinalysis solutions, has received ISO 9001:2015 certification to sale, distribute, and install clinical diagnostic equipment in laboratories, hospitals, and healthcare organizations. Moreover, according to report published in MDPI journal of pharmaceutics in 2020, Malaysia has been ranked as the highest diabetes cases recorded in Asia, with around 3.6 million patients. By 2025, it is expected that around seven million adults will suffer from diabetes. Therefore, increasing screening of diabetes and other non-communicable as well as infectious diseases might provide significant growth opportunities for urinalysis market in rest of the APAC region during the forecast period.

Key Market Segments

APAC urinalysis market is segmented into product, test type, application, end user, and country. Based on product, the APAC urinalysis market is segmented into consumables and instruments. The consumables segment is expected to hold a larger market share in 2021. The APAC urinalysis market, based on test type, is segmented into pregnancy and fertility tests, biochemical urinalysis, and sediment urinalysis. The biochemical urinalysis segment would hold the largest share of the market in 2021. Based on application, the APAC urinalysis market is segmented into disease screening and pregnancy, and fertility. The disease screening segment would account for a larger market share in 2021. The APAC urinalysis market, by end user, is segmented into hospitals and clinics, diagnostic laboratories, home care settings, and research laboratories and institutes. The hospitals and clinics segment would hold the largest share of the market in 2021. Based on country, the APAC urinalysis market is segmented into Australia, China, India, Japan, South Korea, and rest of APAC. China held the largest market share in 2021.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the urinalysis market in APAC are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Abbott; ACON Laboratories, Inc.; ARKRAY, Inc.; Beckman Coulter, Inc.; Bio-Rad Laboratories Inc.; Cardinal Health Inc; F. Hoffmann-La Roche Ltd.; Quidel Corporation; Siemens Healthineers AG; and Sysmex Corporation.         

Reasons to buy report

  • To understand the APAC urinalysis market landscape and identify market segments that are most likely to guarantee a strong return.
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for APAC urinalysis market.
  • Efficiently plan M&A and partnership deals in APAC urinalysis market by identifying market segments with the most promising probable sales.
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form APAC urinalysis market.
  • Obtain market revenue forecast for market by various segments from 2021-2028 in APAC region.

APAC Urinalysis Market Segmentation

APAC Urinalysis Market - By Product

  • Consumables
  • Instruments

APAC Urinalysis Market - By Test Type

  • Pregnancy and Fertility Tests
  • Biochemical Urinalysis
  • Sediment Urinalysis

APAC Urinalysis Market - By Application

  • Disease Screening
  • Pregnancy and Fertility

APAC Urinalysis Market - By End User

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Home Care Settings
  • Research Laboratories and Institutes

APAC Urinalysis Market - By Country

  • Australia
  • China
  • India
  • Japan
  • South Korea
  • Rest of APAC

APAC Urinalysis Market - Company Profiles

  • Abbott    
  • ACON Laboratories, Inc.             
  • ARKRAY, Inc.     
  • Beckman Coulter, Inc.     
  • Bio-Rad Laboratories Inc.            
  • Cardinal Health Inc         
  • F. Hoffmann-La Roche Ltd.          
  • Quidel Corporation          
  • Siemens Healthineers AG           
  • Sysmex Corporation

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        APAC Urinalysis Market – By Product

1.3.2        APAC Urinalysis Market – By Test Type

1.3.3        APAC Urinalysis Market – By Application

1.3.4        APAC Urinalysis Market – By End User

1.3.5        APAC Urinalysis Market – By Country

2.           APAC Urinalysis Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           APAC Urinalysis Market – Market Landscape

4.1         Overview

4.1.1        APAC– PEST Analysis

4.2         Expert Opinions

5.           APAC Urinalysis Market– Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Cases of Urinary Tract Infection, Diabetes, and Kidney Diseases

5.1.2        Surge in Geriatric Population

5.2         Market Restraints

5.2.1        Product Recalls and Tough Regulatory Requirements

5.3         Market Opportunities

5.3.1        Enhancing Laboratory Infrastructure in Developing Countries

5.4         Future Trends

5.4.1        Market Players are Launching More Products and Implementing More Strategic Initiatives

5.5         Impact Analysis

6.           Urinalysis Market – APAC Analysis

6.1         APAC Urinalysis Market Revenue Forecast and Analysis

7.           APAC Urinalysis Market Analysis – By Product

7.1         Overview

7.2         APAC Urinalysis Market Share by Products 2021 & 2028 (%)

7.3         Consumable

7.3.1        Overview

7.3.2        Consumables Market Revenue and Forecast to 2028 (US$ Mn)

7.4         Instruments

7.4.1        Overview

7.4.2        Instruments Market Revenue and Forecast to 2028 (US$ Mn)

8.           APAC Urinalysis Market Analysis – By Test Type

8.1         Overview

8.1.1        APAC Urinalysis Market, By Test Type 2021 & 2028 (%)

8.2         Pregnancy and Fertility Tests Market

8.2.1        Overview

8.2.2        APAC Pregnancy and Fertility Tests Market Revenue and Forecasts to 2028 (US$ Million)

8.3         Biochemical Urinalysis

8.3.1        Overview

8.3.2        APAC Biochemical Urinalysis Market Revenue and Forecasts to 2028 (US$ Million)

8.4         Sediment Urinalysis

8.4.1        Overview

8.4.2        APAC Sediment Urinalysis Market Revenue and Forecasts to 2028 (US$ Million)

9.           APAC Urinalysis Market Analysis – By Application

9.1         Overview

9.2         APAC Urinalysis Market Share by Application 2021 & 2028 (%)

9.3         Disease Screening

9.3.1        Overview

9.3.2        Disease Screening Market Revenue and Forecast to 2028 (US$ Mn)

9.4         Pregnancy and Fertility

9.4.1        Overview

9.4.2        Pregnancy and Fertility Market Revenue and Forecast to 2028 (US$ Mn)

10.        APAC Urinalysis Market Analysis – By End User

10.1      Overview

10.2      APAC Urinalysis Market Share, by End User, 2021 and 2028 (%)

10.3      Hospitals and Clinics

10.3.1     Overview

10.3.2     Hospitals and Clinics: Urinalysis Market– Revenue and Forecast to 2028 (US$ Million)

10.4      Diagnostic Laboratories

10.4.1     Overview

10.4.2     Diagnostic Laboratories: Urinalysis Market– Revenue and Forecast to 2028 (US$ Million)

10.5      Home Care Settings

10.5.1     Overview

10.5.2     Home Care Settings: Urinalysis Market– Revenue and Forecast to 2028 (US$ Million)

10.6      Research Laboratories and Institutes

10.6.1     Overview

10.6.2     Research Laboratories and Institutes: Urinalysis Market– Revenue and Forecast to 2028 (US$ Million)

11.        APAC Urinalysis Market – Country Analysis

11.1      Overview

11.1.2     APAC: Urinalysis Market, by Country, 2021 & 2028 (%)

11.1.2.1       China: Urinalysis Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.1.1       China: Urinalysis Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.1.2       China: Urinalysis Market, By Products, 2019–2028 (USD Million)

11.1.2.1.3       China: Urinalysis Market, By Test Type, 2019–2028 (USD Million)

11.1.2.1.4       China: Urinalysis Market, by Application, 2019–2028 (USD Million)

11.1.2.1.5       China: Urinalysis Market, by End User, 2019–2028 (USD Million)

11.1.2.2       Japan: Urinalysis Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.2.1       Japan: Urinalysis Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.2.2       Japan: Urinalysis Market, By Products, 2019–2028 (USD Million)

11.1.2.2.3       Japan: Urinalysis Market, By Test Type, 2019–2028 (USD Million)

11.1.2.2.4       Japan: Urinalysis Market, by Application, 2019–2028 (USD Million)

11.1.2.2.5       Japan: Urinalysis Market, by End User, 2019–2028 (USD Million)

11.1.2.3       India: Urinalysis Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.3.1       India: Urinalysis Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.3.2       India: Urinalysis Market, By Products, 2019–2028 (USD Million)

11.1.2.3.3       India: Urinalysis Market, By Test Type, 2019–2028 (USD Million)

11.1.2.3.4       India: Urinalysis Market, by Application, 2019–2028 (USD Million)

11.1.2.3.5       India: Urinalysis Market, by End User, 2019–2028 (USD Million)

11.1.2.4       Australia: Urinalysis Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.4.1       Australia: Urinalysis Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.4.2       Australia: Urinalysis Market, By Products, 2019–2028 (USD Million)

11.1.2.4.3       Australia: Urinalysis Market, By Test Type, 2019–2028 (USD Million)

11.1.2.4.4       Australia: Urinalysis Market, by Application, 2019–2028 (USD Million)

11.1.2.4.5       Australia: Urinalysis Market, by End User, 2019–2028 (USD Million)

11.1.2.5       South Korea: Urinalysis Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.5.1       South Korea: Urinalysis Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.5.2       South Korea: Urinalysis Market, By Products, 2019–2028 (USD Million)

11.1.2.5.3       South Korea: Urinalysis Market, By Test Type, 2019–2028 (USD Million)

11.1.2.5.4       South Korea: Urinalysis Market, by Application, 2019–2028 (USD Million)

11.1.2.5.5       South Korea: Urinalysis Market, by End User, 2019–2028 (USD Million)

11.1.2.6       Rest of APAC: Urinalysis Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.6.1       Rest of APAC: Urinalysis Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.6.2       Rest of APAC: Urinalysis Market, By Products, 2019–2028 (USD Million)

11.1.2.6.3       Rest of APAC: Urinalysis Market, By Test Type, 2019–2028 (USD Million)

11.1.2.6.4       Rest of APAC: Urinalysis Market, by Application, 2019–2028 (USD Million)

11.1.2.6.5       Rest of APAC: Urinalysis Market, by End User, 2019–2028 (USD Million)

12.        Impact Of COVID-19 Pandemic on APAC Urinalysis Market

12.1      APAC: Impact Assessment of COVID-19 Pandemic

13.        Urinalysis Market–Industry Landscape

13.1      Overview

13.2      Growth Strategies in the Urinalysis Market (%)

13.3      Organic Developments

13.3.1     Overview

13.4      Inorganic Developments

13.4.1     Overview

14.        COMPANY PROFILES

14.1      Abbott

14.1.1     Key Facts

14.1.2     Business Description

14.1.3     Products and Services

14.1.4     Financial Overview

14.1.5     SWOT Analysis

14.1.6     Key Developments

14.2      ACON Laboratories, Inc.

14.2.1     Key Facts

14.2.2     Business Description

14.2.3     Products and Services

14.2.4     Financial Overview

14.2.5     SWOT Analysis

14.2.6     Key Developments

14.3      ARKRAY, Inc.

14.3.1     Key Facts

14.3.2     Business Description

14.3.3     Products and Services

14.3.4     Financial Overview

14.3.5     SWOT Analysis

14.3.6     Key Developments

14.4      Beckman Coulter, Inc. (Danaher Corporation Subsidiary)

14.4.1     Key Facts

14.4.2     Business Description

14.4.3     Products and Services

14.4.4     Financial Overview

14.4.5     SWOT Analysis

14.4.6     Key Developments

14.5      BIO-RAD LABORATORIES INC.

14.5.1     Key Facts

14.5.2     Business Description

14.5.3     Products and Services

14.5.4     Financial Overview

14.5.5     SWOT Analysis

14.5.6     Key Developments

14.6      Cardinal Health Inc.

14.6.1     Key Facts

14.6.2     Business Description

14.6.3     Products and Services

14.6.4     Financial Overview

14.6.5     SWOT Analysis

14.6.6     Key Developments

14.7      F. HOFFMANN-LA ROCHE LTD.

14.7.1     Key Facts

14.7.2     Business Description

14.7.3     Products and Services

14.7.4     Financial Overview

14.7.5     SWOT Analysis

14.7.6     Key Developments

14.8      Quidel Corporation

14.8.1     Key Facts

14.8.2     Business Description

14.8.3     Products and Services

14.8.4     Financial Overview

14.8.5     SWOT Analysis

14.8.6     Key Developments

14.9      Siemens Healthineers AG

14.9.1     Key Facts

14.9.2     Business Description

14.9.3     Products and Services

14.9.4     Financial Overview

14.9.5     SWOT Analysis

14.9.6     Key Developments

14.10   Sysmex Corporation

14.10.1  Key Facts

14.10.2  Business Description

14.10.3  Products and Services

14.10.4  Financial Overview

14.10.5  SWOT Analysis

14.10.6  Key Developments

15.        Appendix

15.1      About the Insight Partners

15.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             China: Urinalysis Market, By Products – Revenue and Forecast to 2028 (USD Million)

Table 2.             China: Urinalysis Market, By Test Type – Revenue and Forecast to 2028 (USD Million)

Table 3.             China: Urinalysis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 4.             China: Urinalysis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 5.             Japan: Urinalysis Market, By Products– Revenue and Forecast to 2028 (USD Million)

Table 6.             Japan: Urinalysis Market, By Test Type– Revenue and Forecast to 2028 (USD Million)

Table 7.             Japan: Urinalysis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 8.             Japan: Urinalysis Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 9.             India: Urinalysis Market, By Products– Revenue and Forecast to 2028 (USD Million)

Table 10.          India: Urinalysis Market, By Test Type – Revenue and Forecast to 2028 (USD Million)

Table 11.          India: Urinalysis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 12.          India: Urinalysis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 13.          Australia: Urinalysis Market, By Products – Revenue and Forecast to 2028 (USD Million)

Table 14.          Australia: Urinalysis Market, By Test Type– Revenue and Forecast to 2028 (USD Million)

Table 15.          Australia: Urinalysis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 16.          Australia: Urinalysis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 17.          South Korea: Urinalysis Market, By Products – Revenue and Forecast to 2028 (USD Million)

Table 18.          South Korea: Urinalysis Market, By Test Type – Revenue and Forecast to 2028 (USD Million)

Table 19.          South Korea: Urinalysis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 20.          South Korea: Urinalysis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 21.          Rest of APAC: Urinalysis Market, By Products – Revenue and Forecast to 2028 (USD Million)

Table 22.          Rest of APAC: Urinalysis Market, By Test Type – Revenue and Forecast to 2028 (USD Million)

Table 23.          Rest of APAC: Urinalysis Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 24.          Rest of APAC: Urinalysis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 25.          Organic Developments in the Urinalysis Market

Table 26.          Inorganic Developments in the Urinalysis Market

Table 27.          Glossary of Terms, APAC Urinalysis Market

 


LIST OF FIGURES

Figure 1.           APAC Urinalysis Market Segmentation

Figure 2.           APAC Urinalysis Market Segmentation, By Country

Figure 3.           APAC Urinalysis Market Overview

Figure 4.           Consumables Segment Held the Largest Share of the Product Segment in APAC Urinalysis Market

Figure 5.           China to Show Significant Growth During Forecast Period

Figure 7.           APAC PEST Analysis

Figure 8.           APAC Urinalysis Market Impact Analysis of Driver and Restraints

Figure 9.           APAC Urinalysis Market – Revenue Forecast and Analysis – 2019- 2028

Figure 10.        APAC Urinalysis Market Share by Products 2021 & 2028 (%)

Figure 11.        APAC Consumables Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12.        APAC Instruments Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13.        APAC Urinalysis Market, By Test Type 2021 & 2028 (%)

Figure 14.        APAC Pregnancy and Fertility Tests Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15.        APAC Biochemical Urinalysis Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16.        APAC Sediment Urinalysis Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17.        APAC Urinalysis Market Share by Application 2021 & 2028 (%)

Figure 18.        APAC Disease Screening Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 19.        APAC Pregnancy and Fertility Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 20.        APAC Urinalysis Market Share, by End User, 2021 and 2028 (%)

Figure 21.        APAC Hospitals and Clinics: Urinalysis Market– Revenue and Forecast to 2028 (US$ Million)

Figure 22.        APAC Diagnostic Laboratories: Urinalysis Market– Revenue and Forecast to 2028 (US$ Million)

Figure 23.        APAC Home Care Settings: Urinalysis Market– Revenue and Forecast to 2028 (US$ Million)

Figure 24.        APAC Research Laboratories and Institutes: Urinalysis Market– Revenue and Forecast to 2028 (US$ Million)

Figure 25.        APAC: Urinalysis Market, by Key Country – Revenue (2021) (USD Million)

Figure 26.        APAC: Urinalysis Market, by Country, 2021 & 2028 (%)

Figure 27.        China: Urinalysis Market – Revenue and Forecast to 2028 (USD Million)

Figure 28.        Japan: Urinalysis Market – Revenue and Forecast to 2028 (USD Million)

Figure 29.        India: Urinalysis Market – Revenue and Forecast to 2028 (USD Million)

Figure 30.        Australia: Urinalysis Market – Revenue and Forecast to 2028 (USD Million)

Figure 31.        South Korea: Urinalysis Market – Revenue and Forecast to 2028 (USD Million)

Figure 32.        Rest of APAC: Urinalysis Market – Revenue and Forecast to 2028 (USD Million)

Figure 33.        Impact of COVID-19 Pandemic in APAC Country Markets

Figure 34.        Growth Strategies in the Urinalysis Market (%)

 

  1. Abbott    
  2. ACON Laboratories, Inc.             
  3. ARKRAY, Inc.     
  4. Beckman Coulter, Inc.     
  5. Bio-Rad Laboratories Inc.            
  6. Cardinal Health Inc         
  7. F. Hoffmann-La Roche Ltd.          
  8. Quidel Corporation          
  9. Siemens Healthineers AG           
  10. Sysmex Corporation
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the APAC urinalysis market
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the APAC urinalysis market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the urinalysis market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

 

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000